Euractiv Events EURACTIV

Expanding organic farming and agricultural lands in the EU is at the heart of the European Green Deal’s initiatives. Organic farming uses natural substances and processes to produce food and brings environmental, economic and social benefits.
To support European green ambitions, the European Commission launched the Farm to Fork Strategy in 2020. One of its aims is to bolster organic food sales and production with a focus on a fair and sustainable supply chain. This initiative was reinforced through the Organic Action Plan which seeks to achieve 25% of organic agricultural land by 2030. However, currently, only 10% of EU agricultural land is organic.
Organic farming is more labour-intensive and produces lower yields than conventional farmers, while generating similar income. Despite receiving economic support through the CAP, organic farmers feel they remain inadequately remunerated because their selling prices are lower than the retail prices.
While the EU seeks to boost organic farming and food supply, some stakeholders argue that the EU needs a more robust implementation to transition towards fair and organic food systems. Others believe that the text on new genomic technologies (NGTs) approved by the European Parliament could help reach the target on organic agricultural lands.
Join this Euractiv Virtual Conference to discuss the sustainability of organic farming and its implications for reaching European green ambitions. Questions to be addressed include:
How can the EU strengthen the position of organic farmers in the supply chain?How can the gap between organic produce selling prices and retail prices be addressed?How compatible are the NGTs and organic farming in light of the target for agricultural lands set by the European Commission?What steps are needed to further develop organic food supply and demand?Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.

Nuclear power is seen as part of the solution to tackle climate change and meet growing energy needs to decarbonise our economy. Following the Nuclear Energy Summit, jointly organised by the IAEA and Belgium on March 21, 2024, EDF, Fortum, and Vattenfall, in partnership with Euractiv, are preparing an insightful event. We will delve into the central role of nuclear energy, in partnership with renewable energy technologies, in achieving the European Union’s climate, social, and strategic objectives. The event will explore the need for a neutral approach to net-zero technologies, and define the key steps that the nuclear industry will have to take to achieve these goals. Taking up this significant challenge includes the need to inspire and cultivate emerging talent. We should motivate them to eagerly pursue a career path in net zero technologies, contributing to a greener future. Do not miss this opportunity to contribute to shaping the future of net zero energy and making a positive impact on the world. Nuclear Energy 2.0 is more than just a conference. It is an exploration of the next phase in the evolution of the European energy landscape. Get ready for an interactive debate on the potential of nuclear energy!

For the last three decades, the availability of cost-effective generic medicines has driven increased access to life-saving treatments for millions of patients in Europe. Today, generic medicines are an integral part of the healthcare system and demand for these products continues to increase worldwide.
While increased usage of generic medicines has led to unprecedented savings for healthcare systems, many perspectives on this segment remain focused solely on their cost saving potential. This perception can underplay the range of generic medicine contributions to added societal value. Neglecting these contributions can exacerbate the challenges that healthcare systems are facing today.
A case where generic medicines contribute to societal value is by ensuring access, thus helping to reduce disease burden in underserved markets, such as in most Central and Eastern European (CEE) countries.
The report “Beneath the Surface: Unravelling the True Value of Generic Medicines” presented in this online panel explores the broad spectrum of contributions of generic medicines to European health systems, through an examination of their critical role in increasing access, financial sustainability, supply chain resilience and better outcomes for patients.
During this event, panellists and the audience will exchange ideas on:
Creating a regulatory environment that promotes access.The functioning of national markets in ensuring the availability and sustainability of medicines for patients.Coordination at European and National levels to mitigate shortages.Supporting innovation to achieve better health outcomes.

In a new era marked by climate disruptions, geopolitical conflicts and economic tensions, fundamental questions arise: do we still need industry in Europe? Or can the EU rely solely on fragmented value chains for its strategic autonomy? As the EU strives for peace, prosperity and security for its citizens in the next five years and beyond, can it afford to depend on third countries for critical clean technologies essential to the green transition?
Consider nickel, lithium, ferrous scrap, steel, renewables, hydrogen, batteries, electric vehicles, high tech machineries, defence and medical equipment, transportation and energy infrastructure, and more. Though seemingly disparate, all these components share a vital link: each is integral to a unified value chain, wherein the strength of the whole hinges on the resilience of its individual parts.
Can the EU’s resilience be imported or only come from within?
Listen to this EUROFER Conference to discuss thought-provoking questions with high-level EU representatives and policymakers tasked with aligning industrial policy to the green transition, CEOs, business leaders and leading researchers, representing the entire manufacturing value chain - from raw materials and steel to renewables and automotive.
At a crucial time just before the commencement of a new EU cycle, panellists will exchange views on:
The urgent need for a new industrial policy ensuring a robust business case for decarbonisation investments in the EU across the full value chain;The key ingredients to maintain European industry’s competitiveness on global markets, starting from access to affordable clean energy;The critical role of robust trade measures to tackle overcapacity, ensure a level playing field and avert deindustrialisation.

The political term spanning from 2019 to 2024 saw an unprecedented focus on healthcare, not only in terms of the EU’s response to the immediate health crisis triggered by the COVID-19 pandemic, but also making significant strides in addressing longer term healthcare challenges across Europe. Anchored by the goal of building a ‘European Health Union’, notable achievements include the €5.3 billion EU4Health programme, including substantial healthcare investments towards preparednessand response to health threats, the launch of Europe’s Beating Cancer Plan and a European Health Data Space, and foundational steps towards addressing non-communicable diseases (NCDs) through the Healthier Together Initiative. Meanwhile, the proposed revision of the General Pharmaceutical Legislation represents the most significant overhaul of EU medicines policy in over two decades, the debate on which is set to continue into the next institutional cycle.
As the EU confronts mounting health challenges, the growing burden of NCDs compounded by an ageing population, fiscal constraints, persistent health disparities and a health workforce crisis, Europe’s future political leadership must reflect on lessons learned from the last five years, and look to the road ahead to safeguard the resilience and sustainability of Europe’s health systems and economies.
Listen to the discussion with leading policymakers and experts in EU health policy who will explore key questions including:
What are the major successes and lessons learned in health policy during the 2019-2024 institutional mandate?What should the EU’s health policy priorities be for the next political cycle?How can stakeholders across the healthcare ecosystem best collaborate to achieve a successful European Health Union?

Carbon capture, utilisation and storage (CCUS) technologies are crucial for Europe to achieve its climate targets for 2040 and 2050. CCUS solutions can also enhance industrial competitiveness and bolster energy resilience.
It is no coincidence that the European Commission unveiled its Industrial Carbon Management Strategy on the same day as the publication of its 2040 climate target, early February. Without a massive deployment of CCUS technologies, the EU will not be able to decarbonise its industrial activities.
Along with the ICMS, the Net Zero Industry Act emphasises the role of CCUS technologies in reaching Net-Zero by 2050 and being a critical solution in securing the future of European industries.
Listen to this event organised by the Carbon Capture & Storage Association – the leading European CCUS trade association with 120+ members across the entire value chain - to explore the CCUS industry perspective about achieving the CO2 storage targets set by the European Commission.
Key discussion points will include:
Assessing the impact of CCUS on industrial decarbonisation processes.Advancing solutions for compelling business cases to increase CO2 storage and transport infrastructure investments.Identifying key policy measures to promote the use of CCUS technologies.